IMR Press / CEOG / Volume 51 / Issue 4 / DOI: 10.31083/j.ceog5104084
Open Access Original Research
Explanatory Model of Self-Efficacy for Cervical Cancer Screening
Show Less
1 Faculty of Nursing-CISeAL, Pontificia Universidad Católica del Ecuador, 01-17-2184 Pichincha, Ecuador
2 School of Nursing, Faculty of Nursing Universidad Andres Bello, 8370146 Santiago, Chile
3 Department of Public Health, Faculty of Medicine Pontificia Universidad Católica de Chile, 8320165 Santiago, Chile
*Correspondence: maria.urrutia@unab.cl (Maria-Teresa Urrutia)
These authors contributed equally.
Clin. Exp. Obstet. Gynecol. 2024, 51(4), 84; https://doi.org/10.31083/j.ceog5104084
Submitted: 1 December 2023 | Revised: 1 January 2024 | Accepted: 15 January 2024 | Published: 26 March 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: Cervical cancer (CC) screening is a public health concern, and social conditions partially explain the individual’s ability to respond to the preventive aspect of the disease. This study aims to design an explanatory model of self-efficacy (SE) for CC screening. Methods: This study was conducted on 969 women aged 25–64 years who used the public health care system in Santiago, Chile. Multiple linear regression analysis was conducted to generate the explanatory model for global SE index and for each of their components as function of sociodemographic factors, factors related to interaction with the health system, risk factors for CC, family functioning, and the knowledge and beliefs of women regarding the disease and its prevention. Results: The factors that explain high levels of SE are low levels of education and knowledge of the risk factors of CC, better beliefs about the barriers to and benefits of a Papanicolaou (Pap) test, participation in breast cancer screening, and highly functional family Apgar. Conclusions: To administer as many CC screening as possible, achieve effective interventions, and reach optimal coverage rates, it is necessary to consider social determinants, collaborate with other cancer screening programs, and work toward the beliefs of the population.

Keywords
Papanicolaou test
self-efficacy
uterine cervical neoplasms
1. Introduction

Globally, cervical cancer (CC) is the fourth most common cancer among women [1]. The incidence of CC can be reduced by up to 90% using good-quality screening procedures and by achieving a coverage rate of more than 80% [2]. The World Health Organization (WHO) global strategy sets three targets to be achieved by the year 2030 to put all countries on the pathway to elimination in the coming decades: 90% of girls vaccinated with the human papilloma virus (HPV) vaccine by age 15; 70% of women screened with a high-quality test by ages 35 and 45; 90% of women with cervical disease receiving treatment. Precancers rarely cause symptoms, which is why regular CC screening is important [1, 3].

Adherence is a crucial indicator that implies the individual willingness to take cervical cancer screening [4]. In 2019, the adherence was at 33.66% worldwide, and was higher in high income countries (75.66%) than in low and middle-income countries (24.91%). Chile adherence to CC screening during 2021 was 42.4% [5].

Regular screening is crucial to ensure screening effectiveness [4]. Various studies have investigated the causes underlying the low coverage rate [6, 7, 8, 9, 10] and the interventions to increase the rate [11, 12, 13]. Although the elements of the social context are evident within the framework of the social determinant model of the WHO [14, 15, 16, 17], limited research has been conducted on the basis of intermediary factors within the control of individuals that influence the expected health behavior, i.e., adherence to the Papanicolaou (Pap) test [18]. Self-efficacy (SE) is a focal determinant because it affects health behavior both directly and by influencing other determinants [19].

According to Bandura et al. [19, 20, 21], individuals are proactive and in control of their behavior instead of reactive and in control of environmental or biological forces; however, they tend to attribute failure in different behaviors to external factors. This suggests the need to analyze the SE of women toward the Pap test. SE refers to a person’s confidence in his or her ability to successfully undertake a specific action [22]. The level of SE influences decision making, the extent of effort, and the duration of persistence in conducting a certain behavior [20]. Other scholars also examined the relationship between SE and adherence to Pap [23, 24, 25] and found that high levels of SE predict adherence to screening [26, 27, 28, 29, 30, 31] as well as intention [28, 32, 33]. Thus, this study aimed to design an explanatory model of SE to evaluate the adherence to Pap.

2. Materials and Methods

This study conducted a secondary data analysis of the National Fund for Scientific and Technological Development #11,130,626 project on the social determinants of adherence to Pap test. The original study included women aged 25–64 years who were covered under the Chilean public health system (National Health Fund [FONASA]) and registered in one of the four primary health care centers of the Puente Alto commune in Santiago, Chile. The sample was selected and stratified by health centers and Pap test coverage levels. According to Pap test coverage data, four primary health care centers were randomly selected with probabilities proportional to their size, one from each group: with the highest coverage, medium-high coverage, medium-low coverage, and low coverage. Using an online calculator and the methodology described by Soper [34], to achieve a small effect size of 0.1 (relationships between instruments), a power of 80%, 15 latent and 40 observed variables, and a level of reliability of 95%, approximately 850 women needed to be interviewed. The sample size of this study was 969 patients. The inclusion criteria were the characteristics of women included in the afore mentioned study. The exclusion criteria were the presence of CC and/or total hysterectomy. In this secondary data analysis, the sample size was 969 cases. In the following analysis, the dependent variable was SE for adherence to Pap, and the independent variables were sociodemographic factors, factors related to interaction with the health system, risk factors for CC, family functioning, and the knowledge and beliefs of women regarding the disease and its prevention. SE in adhering to the Pap was measured using the original Self-Efficacy Scale for Pap Smear Screening Participation (SES-PSSP) [35], which was previously validated in the Chilean population (Cronbach’s alpha = 0.95) [36]. The questionnaire comprises 20 questions distributed into two dimensions: personal cost (e.g., time, money, transportation, and life interruption) and relationships (e.g., opinions of family members and peers; the higher the score, the lower the SE). According to the original recommendation of the author of the questionnaire, 2 items can be added in case the interviewed woman has children and can leave them alone; given that these items are not applicable to all women, the original version does not include them in the dimensions described above and therefore they were not included in this research either. To assess knowledge about CC and its screening, this study used the previously validated knowledge in Cervical Cancer questionnaire (CEC-66) with a Cronbach’s alpha = 0.83 [37]. The scale comprises 66 items, which were distributed into 12 dimensions (location, detection, risk, transmission, prevention, symptoms, Pap smear knowledge, Pap smear requirements, Pap smear frequency, types of vaccine, vaccine requirements, and vaccine dose). The obtained scores were positively correlated with the level of knowledge. To measure beliefs, the study employed previously validated CPC-28 [38], with a Cronbach’s alpha = 0.90, which comprises 28 items categorized under six dimensions (barriers to Pap, cues to action, severity of CC, Pap requirements, susceptibility to CC, and benefits). The obtained scores were positively correlated with the belief. To measure family functioning, the family Apgar validated in the Chilean population was used. The scale comprises four items that are included in one dimension [39]. For data analysis, SPSS version 22 (IBM Corp, Armonk, NY, USA) and R software version 1.0.1 (R Core Team, Vienna, Austria) were used to determine frequency, measures of central tendency, and variability. Furthermore, Pearson’s and Spearman’s correlation coefficients were calculated. Groups were compared using Fisher’s exact test, t-test was used for independent samples. One-way analysis of variance and Levene’s test were used to determine equality of variance. Multiple linear regression analysis was conducted to generate the explanatory model. The selection variables were identified using the Bayesian information criterion (BIC), and significance was set at p < 0.05.

3. Results

The average age of the included participants was 43.47 ± 10.78 years, and 76.5% reported adherence to the Pap test in the last 3 years. The mean of SE score was 34.56 ± 14.67. The SE score ranged from 18 (representing 100% SE) to 90 (representing 0% SE). The mean SE was 77% (Tables 1,2).

Table 1.Descriptive statistics of the sample.
Mean (SD) p10–p90
Age (years) 43.47 (10.78)
Educational level (years) 10.97 (3.40)
Per capita income monthly (USD)a 115 47–270
Number of children 2.33 (1.28)
Age at first intercourse 18.42 (3.57)
Number of partnersa 2 1–5
Self-efficacy questionnaire (20 items) 34.56 (14.67)
Personal costs (10 items) 21.6 (10.28)
Relationship (8 items) 12.96 (5.36)
Knowledge questionnaire (65 items) 4 0–17
Locationa (3 items) 0 0–1
Detectiona (3 items) 0 0–2
Riska (15 items) 1 0–5
Transmissiona (4 items) 0 0–2
Preventiona (4 items) 1 0–3
Symptomsa (6 items) 0 0–0
Pap smear knowledgea (3 items) 0 0–1
Pap smear requirementsa (8 items) 0 0–1
Pap smear frequencya (5 items) 0 0–1
Types of vaccinea (3 items) 0 0–1
Vaccine requirementsa (6 items) 0 0–1
Vaccine dosea (5 items) 0 0–1
Beliefs questionnaire (28 items) 85.45 (8.43)
Barriers to Pap (9 items) 25.4 (4.35)
Cues to action (6 items) 16.07 (3.63)
Severity of CC (4 items) 14.32 (1.88)
Pap requirements (3 items) 9.28 (1.41)
Susceptibility to CC (3 items) 9.6 (1.53)
Benefits (3 items) 10.78 (1.34)

a The values are median and percentiles. Pap, Papanicolaou; CC, cervical cancer; USD, United States dollar; SD, standard deviation.

Table 2.Descriptive categorical variables of the sample.
n %
Adherence to the Pap test in the last 3 years 741 76.5
Paid employment 617 63.7
Relationship status (with a partner) 767 79.2
Has children 904 93.3
Participation in the preventive medicine program (PMP) 336 34.7
Adherence to breast cancer screeninga
Yes 220 91.3
No 21 8.7
Adherence to gallbladder cancer screeninga
Yes 188 46.9
No 213 53.1
Contact with health care professional (HCP) in the last year 739 76.3
Sexual activity 722 74.5
History of sexually transmitted diseases (STD) 73 7.5
History of cervical cancer in the family 176 18.16
Condom use
Always 65 6.8
Almost always 85 8.8
Hardly ever 102 10.6
Never 709 73.8
Homeowner 614 63.4
Overcrowding 105 10.8
Family Apgar
Severely dysfunctional 73 7.5
Moderately functional 144 14.9
Highly functional 752 77.6
Indigenous people 77 7.9
Cardiovascular diseases 198 20.4
Metabolic diseases 180 18.6
Neuropsychiatric diseases 58 6
Tobacco 379 39.1
Alcohol 338 34.9

a The results were calculated for the target group.

Table 3 shows the mean scores and standard deviations for the socioeconomic, morbidity, and lifestyle characteristics of the population. In cases where the analysis of variance (ANOVA) test is performed, only the p value of the omnibus test is shown, without post-hoc comparisons being made. Table 3 indicates that having children, participating in preventive medicine programs, undergoing breast and gallbladder cancer screening, having a history of a sexually transmitted disease, having undergone a Pap test, owning a home, being indigenous women, having a highly functional family Apgar, and having a metabolic disease are characteristics associated with high levels of SE. Overcrowding as a family condition was associated with low SE levels in terms of personal cost; alcohol consumption and paid employment were associated with low SE levels in terms of relationship. Notably, women who had contact with a health care professional (HCP) during the last year exhibited high levels of SE in the three scores (total, personal cost and relationship).

Table 3.Self-efficacy (SE) scores according to sample characteristics.
Answer n SE total score Personal cost Relationship
Mean (SD) p value Mean (SD) p value Mean (SD) p value
Relationship status Yes 767 34.49 (14.59) 0.767 21.61 (10.29) 0.987 12.89 (5.26) 0.423
No 202 34.84 (15.02) 21.59 (10.27) 13.24 (5.73)
Paid employment Yes 617 35.05 (14.90) 0.174 21.82 (10.42) 0.385 13.23 (5.43) 0.040
No 352 33.72 (14.23) 21.22 (10.04) 12.49 (5.23)
Children Yes 904 34.15 (14.51) 0.001 21.35 (10.21) 0.005 12.80 (5.28) <0.001
No 65 40.29 (15.80) 25.09 (10.70) 15.20 (5.97)
Participation in PMPs Yes 336 31.36 (13.18) <0.001 19.48 (9.45) <0.001 11.88 (4.70) <0.001
No 633 36.26 (15.14) 22.73 (10.54) 13.53 (5.60)
Breast cancer screening Yes 548 31.61 (13.56)a <0.001 19.70 (9.62)a <0.001 11.91 (4.81)a <0.001
No 21 45.48 (13.89)b 29.14 (9.72)b 16.33 (5.89)b
NA 400 38.04 (15.17)b 23.82 (10.58)b 14.22 (5.71)b
Gallbladder cancer screening Yes 480 32.86 (14.13)a <0.001 20.44 (10.04)a 0.001 12.42 (5.01)a 0.001
No 213 34.77 (14.47)ab 21.86 (10.11)ab 12.91 (5.36)ab
NA 276 37.37 (15.34)b 23.43 (10.59)b 13.94 (5.83)b
Contact with HCP last year Yes 230 38.65 (15.60) <0.001 24.40 (10.89) <0.001 14.25 (5.72) <0.001
No 739 33.29 (14.14) 20.74 (9.94) 12.56 (5.18)
History of STD Yes 73 30.84 (13.06) 0.024 19.49 (9.39) 0.068 11.34 (4.69) 0.003
No 896 34.87 (14.76) 21.78 (10.34) 13.09 (5.40)
Sexual activity Yes 722 34.56 (14.73) 0.998 21.59 (10.34) 0.951 12.97 (5.36) 0.912
No 247 34.57 (14.51) 21.64 (10.14) 12.93 (5.38)
History of CC in the family Yes 176 33.13 (14.82) 0.150 20.81 (10.38) 0.255 12.32 (5.37) 0.079
No 793 34.88 (14.62) 21.78 (10.26) 13.10 (5.35)
Adherence to Pap test last three years Yes 741 31.96 (13.42) <0.001 19.91 (9.60) <0.001 12.05 (4.79) <0.001
No 228 43.02 (15.40) 27.10 (10.54) 15.92 (6.02)
Condom use Always 65 33.82 (15.73) 0.132 20.65 (10.50) 0.094 13.17 (5.97) 0.105
Almost always 85 33.56 (13.87) 20.18 (9.34) 13.39 (5.53)
Hardly ever 102 37.75 (16.22) 23.71 (11.34) 14.05 (5.94)
Never 709 34.39 (14.58) 21.42 (10.13) 12.65 (5.13)
Homeowner Yes 614 33.58 (13.77) 0.008 21.00 (9.70) 0.020 12.58 (5.03) 0.006
No 355 36.26 (15.99) 22.65 (11.16) 13.61 (5.84)
Overcrowding Yes 105 36.93 (16.08) 0.080 23.56 (10.96) 0.039 13.37 (6.07) 0.405
No 864 34.28 (14.47) 21.37 (10.18) 12.91 (5.27)
Family Apgar Severely dysfunctional 73 39.07 (15.58) 24.58 (10.94) 14.49 (5.85)
Moderately functional 144 39.54 (15.16) <0.001 25.44 (10.75) <0.001 14.10 (5.43) 0.001
Highly functional 752 33.17 (14.20) 20.58 (9.90) 12.59 (5.25)
Indigenous people Yes 77 31.69 (12.51) 0.041 19.73 (9.01) 0.063 11.96 (4.42) 0.046
No 892 34.81 (14.82) 21.77 (10.38) 13.05 (5.43)
Cardiovascular disease Yes 198 32.93 (13.19) 0.058 20.57 (9.31) 0.089 12.36 (4.83) 0.057
No 771 34.98 (15.01) 21.87 (10.51) 13.11 (5.48)
Metabolic disease Yes 180 32.58 (13.68) 0.035 20.52 (9.86) 0.116 12.06 (4.99) 0.009
No 789 35.02 (14.86) 21.85 (10.37) 13.16 (5.43)
Neuropsychiatric disease Yes 58 33.59 (15.15) 0.601 21.55 (11.02) 0.968 12.03 (5.26) 0.175
No 911 34.63 (14.64) 21.61 (10.24) 13.02 (5.37)
Tobacco Yes 379 34.25 (14.71) 0.597 21.38 (10.32) 0.581 12.88 (5.28) 0.697
No 590 34.76 (14.65) 21.75 (10.27) 13.01 (5.42)
Alcohol Yes 338 35.61 (15.07) 0.104 22.14 (10.48) 0.239 13.48 (5.48) 0.028
No 631 34.00 (14.43) 21.32 (10.17) 12.68 (5.28)

NA, not applicable; a,b Values with the same vowels are nonsignificant; values with different vowels are significant.

The higher the age, the lower the SE score; therefore, the higher the SE; the opposite occurs with level of education, i.e., the higher the level of education, the lower the level of SE (Table 4). In the knowledge questionnaire, only one dimension was correlated with SE, which indicates that the higher the score for knowledge, the higher the SE score, and therefore the lower the SE. According to the results of the correlations of the beliefs questionnaire, three (barriers, benefit, and requirements) of the six dimensions were correlated with the total score for SE, which demonstrates that the higher the score for beliefs, the lower the score for SE, and, therefore, higher the SE.

Table 4.Correlations of SE score with sample characteristics.
n SE total score Score for personal cost Score for relationship
Correlation p value Correlation p value Correlation p value
Age (years) 969 −0.173 <0.001 −0.147 <0.001 −0.191 <0.001
Number of childrena 969 −0.029 0.361 −0.018 0.583 −0.063 0.051
Education (years) 969 0.086 0.007 0.059 0.065 0.122 <0.001
Age at first intercourse 959 −0.028 0.384 −0.011 0.737 −0.056 0.082
Number of partnersa 962 0.035 0.273 0.027 0.406 0.063 0.0497
Frequency of condom use 961 −0.016 0.612 0.004 0.907 −0.058 0.075
Knowledge questionnairea 942 0.062 0.058 0.076 0.020 0.036 0.269
Locationa 969 0.046 0.153 0.054 0.091 0.022 0.497
Detectiona 968 0.057 0.078 0.059 0.066 0.052 0.107
Risk factora 959 0.089 0.006 0.096 0.003 0.069 0.033
Transmissiona 962 0.013 0.698 0.028 0.380 −0.005 0.889
Preventiona 965 0.021 0.512 0.044 0.171 −0.019 0.565
Symptomsa 964 −0.005 0.880 −0.006 0.848 −0.002 0.955
Pap smear knowledgea 968 −0.008 0.809 0.003 0.927 −0.023 0.482
Pap smear requirementsa 967 −0.011 0.743 −0.007 0.833 −0.020 0.533
Pap smear frequencya 969 −0.061 0.059 −0.056 0.084 −0.052 0.107
Types of vaccinea 960 0.058 0.071 0.063 0.053 0.041 0.203
Vaccine requirementsa 964 0.002 0.960 0.012 0.714 −0.007 0.833
Vaccine dosea 968 0.015 0.636 0.023 0.479 0.001 0.964
Beliefs questionnaire 968 −0.082 0.011 −0.063 0.050 −0.103 0.001
Barriers to Pap 968 −0.375 <0.001 −0.364 <0.001 −0.326 <0.001
Cues to action 968 0.026 0.421 0.023 0.471 0.032 0.320
Severity of CC 968 −0.023 0.484 0.002 0.958 −0.064 0.045
Requirements to Pap 969 −0.167 <0.001 −0.145 <0.001 −0.183 <0.001
Susceptibility to CC 966 −0.055 0.085 −0.041 0.208 −0.076 0.018
Benefits 969 −0.073 0.024 −0.045 0.166 −0.111 0.001

a Spearman’s correlation.

This study developed an explanatory model based on the studied variables. Based on the BIC, the study selected the variables from the model. The variables in Table 5 were selected to establish the final model for total scores for SE and the two dimensions. The predictive value of the SE models ranged between 19% and 23%. Of the total variables in the final model, five can be found in the three models. The factors that explained the high levels of SE were low levels of education and knowledge about the risk factors of CC, better beliefs about the barriers to and benefits of Pap, participation in breast cancer screening, and a highly functional family Apgar. The age and history of sexually transmitted diseases are the other factors that explained SE from the relationship dimension.

Table 5.Final models for scores for SE and the personal cost and relationship dimensions.
Variables Total score for SE Personal cost Relationship
R-squared: 0.2357 R-squared: 0.2178 R-squared: 0.1975
Adjusted R-squared: 0.2291 Adjusted R-squared: 0.2119 Adjusted R-squared: 0.1907
Estimate St. Error p value Estimate St. Error p value Estimate St. Error p value
Intercept 67.0157 4.4191 <0.001 37.6739 2.0090 <0.001 31.08880 1.84150 <0.001
Age (years) −0.08259 0.01558 <0.001
Education (years) 0.5041 0.1302 <0.001 0.29057 0.09207 0.00165 0.17163 0.05054 <0.001
Knowledge questionnaire–risk factor dimension 0.9471 0.1886 <0.001 0.57890 0.12499 <0.001 0.29264 0.07075 <0.001
Beliefs questionnaire—barrier dimensions −1.2515 0.1024 <0.001 −0.89205 0.07197 <0.001 −0.39723 0.03808 <0.001
Beliefs questionnaire—benefit dimensions −1.0568 0.3478 0.002446 −0.65676 0.13025 <0.001
History of sexually transmitted infection −1.64616 0.60019 0.006209
Breast cancer screening—no participationa 7.6139 2.9968 0.011224 5.48535 2.11941 0.00980
Breast cancer screening—not applicablea 5.1756 0.8737 <0.001 3.35402 0.61931 <0.001
Familiar Apgar—severely dysfunctionalb 5.5009 1.6124 <0.001 3.42993 1.14101 0.00272 2.19375 0.60570 <0.001
Familiar Apgar—moderately dysfunctional 5.5306 1.1980 <0.001 4.18391 0.84925 <0.001 1.36649 0.44992 0.002455

a The reference category for breast cancer screening is participation.

b Family Apgar: the reference category is highly functional.

4. Discussion

From the behaviorist approach, Bandura [21] suggested SE as an element for determining the individual capacity to respond to a preventive aspect. Analysis of the factors that predict adherence to the Pap is relevant for the reduction of morbidity and mortality due to CC. It is important to recognize that most research has been conducted on how SE predicts adherence to CC screening; however, limited studies have been conducted on the predictors of SE for Pap. Therefore, the major contribution of this study is the explanatory model that provides information on SE for Pap, which can be used in clinical and research settings. However, the model only explains 23% of the variable, which indicates that variables not examined in this study should be examined as predictors of SE. The main limitation of this study is its cross-sectional nature where a temporality of the variables was assumed. Therefore, longitudinal studies for validating the reported results are warranted.

A woman who is self-efficacious in taking Pap will more likely adhere to the screening. This study demonstrated the relationship between SE and adherence to Pap screening, as described in previous studies [23, 24, 25, 27, 28]. Therefore, obtaining high levels of SE is an important target that must be considered in future interventions for CC prevention.

The study results are consistent with previously reported findings on SE predictors; however, the difference is the direction in which some variables were studied, such as education and knowledge of women. The level of education has been described as a predictor of SE [40, 41], and it is one of the most important variables described in the literature related to CC screening [25]. Thus, it can be expected that high education levels indicate greater SE [40]. However, our study yielded contrasting results. This difference can be attributed to the highly demanding work environment of women with a high education level, which makes them less capable of attending screening. Notably, the univariate analysis revealed that, specifically in the relationship dimension, the presence of paid work is related with low levels of SE.

Previous studies have reported a relationship between knowledge and SE [18, 23, 25, 41]; however, a negative correlation between knowledge about risk factors and SE for Pap screening was observed in this study. This can be explained by the fear of cancer, which has been described as a psychological barrier [25]. According to this, it should be noted that the Latino population shares a cultural value called “fatalism”; therefore, this population believes that “nothing can be done” about cancer, which acts as a barrier to accessing screening [42, 43, 44]. Women with high fatalism tendencies have a more negative attitude toward the early diagnosis of CC, and their participation rate in screening programs is low [42].

Beliefs about CC have been an important topic of research [45, 46, 47], and they were one of the main predicting factors for SE in this study, specifically using the barriers and benefits dimensions of the questionnaire. The Health Belief Model is a framework that establishes five components explaining the health behaviors; it was used to assess CC screening in this case [46, 48, 49, 50]; two of the five components are barriers and benefits. Some barriers included the fear of the screening [8, 25, 51], embarrassment about discomfort experienced during the screening process [25, 51] and disclosing sexual history [52]. The results also demonstrate that beliefs about CC screening and SE are positively correlated. If women perceive low barriers and/or high benefits of CC screening, they will feel self-efficacious and will therefore undergo screening. This has been demonstrated in a previous study [53]. Scholars have described educational workshops as efficient interventions for increasing adherence to the Pap test [11]; however, it is crucial to elucidate the components that should be included in these workshops. According to the results, including aspects that decrease the barriers, improve perceptions about the benefits, and address the issue of risk factors with caution could be promising components for these workshops.

Scholars have described personal screening history and perception of CC as factors related to SE [52]. This study found that participation in breast cancer screening predicted SE for Pap screening. Therefore, it is an important factor in promoting an increase in adherence to CC screening. Participation in breast cancer screening is one of the variables that is considered a part of the interaction, i.e., contact with the health care system is a good predictor of adherence to the guidelines of the screening test [54, 55]. Poor access routes to health facilities are an aspect related to poor CC screening [56]; therefore, patient navigation is one of the theoretical frameworks that exhibited positive results in interventions to increase adherence to screening [57, 58, 59, 60].

Better family functioning has been associated with different health outcomes [61, 62, 63, 64]. Regarding family Apgar as a predictor of SE for Pap screening, scholars posit that family could influence an individual’s decision about screening [25], and the lack of spousal or family support could hinder participation in screening [8]. A recent Indonesian study conducted in a rural area revealed that help from husbands had a direct impact on the use of Pap screening, and SE played a mediating role in the relationship between help from husbands and the use of visual inspection with acetic acid.

5. Conclusions

Several factors influence access along the pathway to CC screening, and no single factor could entirely explain the observed patterns of cervical screening. To administer as many CC screening as possible, achieve effective interventions, and reach optimal coverage rates, it is necessary to consider social determinants, collaborate with other cancer screening programs, and work toward the beliefs of the population.

Abbreviations

CC, cervical cancer; Pap, Papanicolaou test; WHO, World Health Organization; SE, self-efficacy; PMP, preventive medicine program; HCP, health care professionals.

Availability of Data and Materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Author Contributions

ACYC, MTU and OP designed the research study. ACYC and MTU performed the research. OP provided help and advice on analyzed the data. ACYC, MTU and OP wrote the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript.

Ethics Approval and Consent to Participate

The project was approved by the scientific ethics committee of the Southeast Metropolitan Health Service and each woman signed an informed consent.

Acknowledgment

We sincerely thank every woman who participated in this study.

Funding

This research was funded by FONDECYT, grant number #1130626.

Conflict of Interest

The authors declare no conflict of interest.

References
[1]
World Health Organization. Cervical Cancer 2023. 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer#:~:text=Key%20facts,%2D%20and%20middle%2Dincome%20countries (Accessed: 10 September 2023).
[2]
Beare S, Meglioli A, Burke J, Bandhoe N, Gallardo JL. Saving Women’s Lives in Latin America and the Caribbean: Improving Cervical Cancer Screening and Treatment Quality and Access. Journal of Global Oncology. 2018; 4: 148s.
[3]
Wilailak S, Kengsakul M, Kehoe S. Worldwide initiatives to eliminate cervical cancer. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 2021; 155: 102–106.
[4]
Zhang W, Gao K, Fowkes FJI, Adeloye D, Rudan I, Song P, et al. Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study. Globalization and Health. 2022; 18: 101.
[5]
OECD.stat. Health care utilisation: cervical cancer screening. 2023. Available at: https://stats.oecd.org/index.aspx?queryid=30159 (Accessed: 10 September 2023).
[6]
Sand FL, Urbute A, Ring LL, Kjaer AK, Belmonte F, Kjaer SK. The influence of overweight and obesity on participation in cervical cancer screening: A systematic review and meta-analysis. Preventive Medicine. 2023; 172: 107519.
[7]
Rosato I, Dalla Zuanna T, Tricarico V, Barbiellini Amidei C, Canova C. Adherence to Cervical Cancer Screening Programs in Migrant Populations: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2023; 20: 2200.
[8]
Srinath A, van Merode F, Rao SV, Pavlova M. Barriers to cervical cancer and breast cancer screening uptake in low- and middle-income countries: a systematic review. Health Policy and Planning. 2023; 38: 509–527.
[9]
Damiani G, Basso D, Acampora A, Bianchi CBNA, Silvestrini G, Frisicale EM, et al. The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis. Preventive Medicine. 2015; 81: 281–289.
[10]
Limmer K, LoBiondo-Wood G, Dains J. Predictors of cervical cancer screening adherence in the United States: a systematic review. Journal of the Advanced Practitioner in Oncology. 2014; 5: 31–41.
[11]
Mohamed AA, Shah V, Njeru JW, Wieland ML, Rutten LJF, Prokop LJ, et al. Interventions to Increase Cancer Screening Adherence Among Somali Immigrants in the US and Europe: A Systematic Review. Journal of Immigrant and Minority Health. 2023. (online ahead of prin)
[12]
Zhang D, Advani S, Waller J, Cupertino AP, Hurtado-de-Mendoza A, Chicaiza A, et al. Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review. JCO Global Oncology. 2020; 6: 617–627.
[13]
Caleia AI, Pires C, Pereira JDF, Pinto-Ribeiro F, Longatto-Filho A. Self-Sampling as a Plausible Alternative to Screen Cervical Cancer Precursor Lesions in a Population with Low Adherence to Screening: A Systematic Review. Acta Cytologica. 2020; 64: 332–343.
[14]
Williams-Brennan L, Gastaldo D, Cole DC, Paszat L. Social determinants of health associated with cervical cancer screening among women living in developing countries: a scoping review. Archives of Gynecology and Obstetrics. 2012; 286: 1487–1505.
[15]
Kurani SS, McCoy RG, Lampman MA, Doubeni CA, Finney Rutten LJ, Inselman JW, et al. Association of Neighborhood Measures of Social Determinants of Health with Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest. JAMA Network Open. 2020; 3: e200618.
[16]
Mohan G, Chattopadhyay S. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review. JAMA Oncology. 2020; 6: 1434–1444.
[17]
Bauer C, Zhang K, Xiao Q, Lu J, Hong YR, Suk R. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018. JAMA Network Open. 2022; 5: e2233429.
[18]
Kim K, Xue QL, Walton-Moss B, Nolan MT, Han HR. Decisional balance and self-efficacy mediate the association among provider advice, health literacy and cervical cancer screening. European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society. 2018; 32: 55–62.
[19]
Bandura A. Health promotion by social cognitive means. Health Education & Behavior: the Official Publication of the Society for Public Health Education. 2004; 31: 143–164.
[20]
Bandura A, Adams A. Analysis of Self-Efficacy Theory of behavioral change. Cognitive Therapy and Research. 1977; 1: 287–310.
[21]
Bandura A. Social cognitive theory: an agentic perspective. Annual Review of Psychology. 2001; 52: 1–26.
[22]
Simons-Morton B, McLeroy K, Wendel M. Self regulation and social cognitive theory. In Simons-Morton B, McLeroy K, Wendel M (eds.) Behavior theory in health promotion practice and research (pp. 127–152). Jones & Bartlett Learning: Ontario, Canada. 2012.
[23]
Ghalavandi S, Heidarnia A, Zarei F, Beiranvand R. Knowledge, attitude, practice, and self-efficacy of women regarding cervical cancer screening. Obstetrics & Gynecology Science. 2021; 64: 216–225.
[24]
Bunkarn O, Kusol K. The Relationship between Perceived Self-Efficacy and Cervical Cancer Screening among Village Health Volunteers in Suratthani Province, Thailand. Asian Pacific Journal of Cancer Prevention: APJCP. 2021; 22: 179–183.
[25]
Salehiniya H, Momenimovahed Z, Allahqoli L, Momenimovahed S, Alkatout I. Factors related to cervical cancer screening among Asian women. European Review for Medical and Pharmacological Sciences. 2021; 25: 6109–6122.
[26]
Babazadeh T, Nadrian H, Rezakhani Moghaddam H, Ezzati E, Sarkhosh R, Aghemiri S. Cognitive determinants of cervical cancer screening behavior among housewife women in Iran: An application of Health Belief Model. Health Care for Women International. 2018; 39: 555–570.
[27]
Majdfar Z, Khodadost M, Majlesi F, Rahimi A, Shams M, Mohammadi G. Relationships between Self-Efficacy and Pap Smear Screening in Iranian Women. Asian Pacific Journal of Cancer Prevention: APJCP. 2016; 17: 263–268.
[28]
Kim S, Hmielowski JD. The Influence of Self-efficacy in Medical Drama Television Programming on Behaviors and Emotions that Promote Cervical Cancer Prevention. American Journal of Health Behavior. 2017; 41: 719–727.
[29]
Hajek A, Bock JO, König HH. The role of general psychosocial factors for the use of cancer screening-Findings of a population-based observational study among older adults in Germany. Cancer Medicine. 2017; 6: 3025–3039.
[30]
Gemeda EY, Kare BB, Negera DG, Bona LG, Derese BD, Akale NB, et al. Prevalence and Predictor of Cervical Cancer Screening Service Uptake Among Women Aged 25 Years and Above in Sidama Zone, Southern Ethiopia, Using Health Belief Model. Cancer Control: Journal of the Moffitt Cancer Center. 2020; 27: 1073274820954460.
[31]
Solomon K, Tamire M, Kaba M. Predictors of cervical cancer screening practice among HIV positive women attending adult anti-retroviral treatment clinics in Bishoftu town, Ethiopia: the application of a health belief model. BMC Cancer. 2019; 19: 989.
[32]
Higgins LM, Dirksing KN, Ding L, Morrow CD, Widdice LA, Kahn JA. Adolescents’ intention and self-efficacy to follow Pap testing recommendations after receiving the HPV vaccine. Human Vaccines & Immunotherapeutics. 2016; 12: 1498–1503.
[33]
Tung WC, Smith-Gagen J, Lu M, Warfield M. Application of the Transtheoretical Model to Cervical Cancer Screening in Latina Women. Journal of Immigrant and Minority Health. 2016; 18: 1168–1174.
[34]
Soper DS. A-priori sample size calculator for structural equation models. 2003. Available at: https://www.danielsoper.com/statcalc (Accessed: 10 May 2022).
[35]
Hogenmiller JR, Atwood JR, Lindsey AM, Johnson DR, Hertzog M, Scott JC, Jr. Self-efficacy scale for Pap smear screening participation in sheltered women. Nursing Research. 2007; 56: 369–377.
[36]
Urrutia MT, Padilla O. Validity of a questionnaire on self-efficacy for Pap test adherence screening. Frontiers in Oncology. 2022; 12: 979799.
[37]
Urrutia MT, Concha X, Riquelme G, Padilla O. Knowledge and preventive behaviors related to cervical cancer and human papiloma virus in a group of Chilean adolescents. Revista Chilena de Infectologia. 2012; 29: 600–606. (In Spanish)
[38]
Urrutia MT, Hall R. Beliefs about cervical cancer and Pap test: a new Chilean questionnaire. Journal of Nursing Scholarship: an Official Publication of Sigma Theta Tau International Honor Society of Nursing. 2013; 45: 126–131.
[39]
Montero L. Evaluación Del Funcionamiento Familiar I: Genograma y APGAR Familiar. In Montero L, Dois A (eds.) Manual de Atención de Familias Para Profesionales de La Salud (pp. 117–136.). Ediciones UC: Santiago, Chile. 2012.
[40]
Furnham A, Cheng H. The Big-Five personality factors, cognitive ability, health, and social-demographic indicators as independent predictors of self-efficacy: A longitudinal study. Scandinavian Journal of Psychology. 2023. (online ahead of print)
[41]
Tiraki Z, Yılmaz M. Cervical Cancer Knowledge, Self-Efficacy, and Health Literacy Levels of Married Women. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education. 2018; 33: 1270–1278.
[42]
Duru G, Topatan S. A barrier to participation in cervical cancer screenings: fatalism. Women & Health. 2023; 63: 436–444.
[43]
Peterson CE, Dykens JA, Weine SM, Holt HK, Fleurimont J, Hutten CG, et al. Assessing the interrelationship between stigma, social influence, and cervical cancer prevention in an urban underserved setting: An exploratory study. PloS One. 2022; 17: e0278538.
[44]
Mark KP, Crosby RA, Vanderpool RC. Psychosocial Correlates of Ever Having a Pap Test and Abnormal Pap Results in a Sample of Rural Appalachian Women. The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association. 2018; 34: 148–154.
[45]
Ayanto SY, Belachew Lema T, Wordofa MA. Women’s and health professionals’ perceptions, beliefs and barriers to cervical cancer screening uptake in Southern Ethiopia: a qualitative study. Sexual and Reproductive Health Matters. 2023; 31: 2258477.
[46]
AlShamlan NA, AlOmar RS, AlAbdulKader AM, AlGhamdi FA, Aldakheel AA, Al Shehri SA, et al. Beliefs and Utilization of Cervical Cancer Screening by Female Health Care Workers in Saudi Arabia Using the Health Belief Model: A Nationwide Study. International Journal of Women’s Health. 2023; 15: 1245–1259.
[47]
Barrera Ferro D, Bayer S, Brailsford S, Smith H. Improving intervention design to promote cervical cancer screening among hard-to-reach women: assessing beliefs and predicting individual attendance probabilities in Bogotá, Colombia. BMC Women’s Health. 2022; 22: 212.
[48]
Maseko TN, Huang HC, Lin KC. Cervical cancer screening behavior of African women: The Rosenstock health belief model assessment. Health Care for Women International. 2021; 42: 976–991.
[49]
Abdelmonsef Ahmed HA, Ibrahim Yassin SY, Mohamed Ahmed MS, Yousof Ali HZ. Application of Health Belief Model About Cervical Cancer Screening Among Female Officer Employees In Kafr-El Sheikh University, Egypt. JPMA. the Journal of the Pakistan Medical Association. 2023; 73: S67–S71.
[50]
Belay AS, Asmare WN, Kassie A. Cervical cancer screening utilization and its predictors among women in bench Sheko Zone, Southwest Ethiopia: using health belief model. BMC Cancer. 2023; 23: 472.
[51]
Deguara M, Calleja N, England K. Cervical cancer and screening: knowledge, awareness and attitudes of women in Malta. Journal of Preventive Medicine and Hygiene. 2021; 61: E584–E592.
[52]
Zhang M, Sit JWH, Wang T, Chan CWH. Exploring the sources of cervical cancer screening self-efficacy among rural females: A qualitative study. Health Expectations: an International Journal of Public Participation in Health Care and Health Policy. 2023; 26: 2361–2373.
[53]
Luszczynska A, Durawa AB, Scholz U, Knoll N. Empowerment beliefs and intention to uptake cervical cancer screening: three psychosocial mediating mechanisms. Women & Health. 2012; 52: 162–181.
[54]
Katz ML, Reiter PL, Young GS, Pennell ML, Tatum CM, Paskett ED. Adherence to Multiple Cancer Screening Tests among Women Living in Appalachia Ohio. Cancer Epidemiology, Biomarkers & Prevention: a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2015; 24: 1489–1494.
[55]
Falk D, Cubbin C, Jones B, Carrillo-Kappus K, Crocker A, Rice C. Increasing Breast and Cervical Cancer Screening in Rural and Border Texas with Friend to Friend Plus Patient Navigation. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education. 2018; 33: 798–805.
[56]
Abah AU, Omokhapue A, Adewole A, Usifoh N, Iyanuoluwa OBA. Environmental and psychosocial predictors of cervical cancer screening among women in Gwagwalada Area Council, Abuja, North Central, Nigeria. African Journal of Reproductive Health. 2023; 27: 32–42.
[57]
Mosquera I, Todd A, Balaj M, Zhang L, Benitez Majano S, Mensah K, et al. Components and effectiveness of patient navigation programmes to increase participation to breast, cervical and colorectal cancer screening: A systematic review. Cancer Medicine. 2023; 12: 14584–14611.
[58]
Lewis-Thames MW, Tom LS, Leung IS, Yang A, Simon MA. An examination of the implementation of a patient navigation program to improve breast and cervical cancer screening rates of Chinese immigrant women: a qualitative study. BMC Women’s Health. 2022; 22: 28.
[59]
Falk D, Foley K, Weaver KE, Jones B, Cubbin C. An Evaluation of Breast and Cervical Cancer Screening Outcomes in an Education and Patient Navigation Program in Rural and Border Texas. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education. 2022; 37: 1043–1052.
[60]
Li Y, Carlson E, Villarreal R, Meraz L, Pagán JA. Cost-effectiveness of a patient navigation program to improve cervical cancer screening. The American Journal of Managed Care. 2017; 23: 429–434.
[61]
Zhang H, Wang Y, Cai X, Tang N, Wei S, Yang Y. Family functioning and health-related quality of life of inpatients with coronary heart disease: a cross-sectional study in Lanzhou city, China. BMC Cardiovascular Disorders. 2022; 22: 397.
[62]
León-Hernández R, Rodríguez-Pérez AC, Pérez-González YM, de Córdova MIP, de León-Escobedo R, Gómez-Gutiérrez T, et al. Psychosocial Factors Associated with Self-Management in Patients with Diabetes. Healthcare (Basel, Switzerland). 2023; 11: 1284.
[63]
Romero-Rodríguez E, Amezcua-Prieto C, Morales-Suárez-Varela M, Pérez CA, Mateos-Campos R, Marcos-Delgado A, et al. Alcohol use and family-related factors among Spanish university students: the unHicos project. BMC Public Health. 2022; 22: 1573.
[64]
Wu Z, Zou Z, Wang F, Xiang Z, Zhu M, Long Y, et al. Family functioning as a moderator in the relation between perceived stress and psychotic-like experiences among adolescents during COVID-19. Comprehensive Psychiatry. 2021; 111: 152274.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share
Back to top